Video
The evolving field of precision medicine is very much reliant on diagnostics, Howard K. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, said at The American Journal of Managed Care's Patient-Centered Oncology Care meeting.
The evolving field of precision medicine is really reliant on diagnostics, Howard K. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, said at The American Journal of Managed Care’s Patient-Centered Oncology Care meeting in Baltimore, Maryland, November 13-14.
Diagnostics can define mutations and genetics of an individual tumor and allow providers to design therapeutic plans as a result.
“As drugs get developed, I think having companion diagnostics, or some connection to that field is going to be increasingly important,” he said.